sancuso
Product Information
Sancuso® is a skin patch that slowly releases the medicine contained in the adhesive (glue), through clean and intact skin areas into the bloodstream while wearing the patch.
| Name | Sancuso® |
| Description | Sancuso® (Granisetron Transdermal System) is the first and only FDA-approved patch for the prevention of Chemotherapy Induced Nausea and Vomiting (CINV) |
| Active substance | Granisetron |
| Indication | A serotonin subtype 3 (5-HT3) receptor antagonist indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days. |
| Strengths | 34.3mg (3.1mg/24 hours) |
| Regulatory Status |
Approved by United States Food and Drug Administration (FDA) in September 2008., Inserts Code #3001566., Revision date 08/08. Registered in KSA, Bahrain, Kuwait, Oman, Qatar, UAE, Lebanon and Tunisia Under registration in Egypt, Algeria and Morocco. |
| Business Partner | Kyowa Hakko Kirin Co. Ltd. |
